Statement Of Cash Flows [Abstract]

Optomed Oyj - Filing #2177087

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations
2,171,000 EUR
2,811,000 EUR
Interest paid, classified as operating activities
76,000 EUR
66,000 EUR
Interest received, classified as operating activities
0 EUR
1,000 EUR
Cash flows from (used in) operating activities
2,370,000 EUR
2,940,000 EUR
Cash flows from (used in) investing activities [abstract]
Purchase of property, plant and equipment, classified as investing activities
780,000 EUR
462,000 EUR
Purchase of intangible assets, classified as investing activities
2,249,000 EUR
2,112,000 EUR
Cash flows from (used in) investing activities
3,029,000 EUR
2,574,000 EUR
Cash flows from (used in) financing activities [abstract]
Proceeds from issuing shares
9,012,000 EUR
1,012,000 EUR
Proceeds from borrowings, classified as financing activities
0 EUR
1,366,000 EUR
Repayments of borrowings, classified as financing activities
912,000 EUR
327,000 EUR
Payments of lease liabilities, classified as financing activities
415,000 EUR
414,000 EUR
Cash flows from (used in) financing activities
7,003,000 EUR
1,637,000 EUR
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
1,605,000 EUR
3,876,000 EUR
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
115,000 EUR
73,000 EUR
Cash and cash equivalents
8,524,000 EUR
6,804,000 EUR
10,608,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.